Compare CLWT & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLWT | BNGO |
|---|---|---|
| Founded | 1971 | 2003 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Professional and commerical equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3M | 12.5M |
| IPO Year | 1996 | 2018 |
| Metric | CLWT | BNGO |
|---|---|---|
| Price | $1.45 | $1.37 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 1.4M | 576.8K |
| Earning Date | 04-30-2026 | 11-12-2026 |
| Dividend Yield | ★ 9.39% | N/A |
| EPS Growth | N/A | ★ 94.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,000,735.00 |
| Revenue This Year | N/A | $12.73 |
| Revenue Next Year | N/A | $34.74 |
| P/E Ratio | $17.56 | ★ N/A |
| Revenue Growth | N/A | ★ 26.26 |
| 52 Week Low | $0.99 | $1.00 |
| 52 Week High | $2.68 | $2.23 |
| Indicator | CLWT | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 51.02 | 42.38 |
| Support Level | $1.46 | $1.10 |
| Resistance Level | $1.74 | $1.46 |
| Average True Range (ATR) | 0.15 | 0.09 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 23.85 | 16.61 |
Euro Tech Holdings Co Ltd is mainly a distributor of a wide range of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies, and power generation equipment, including recorders and power quality analyzers. The Company acts as an exclusive or non-exclusive distributor for manufacturers of such equipment to commercial customers and governmental agencies in Hong Kong and mainland China, as well as commercial customers in Macau. It has two operating segments: Trading and manufacturing, which generate maximum revenue and act as a distributor of water treatment equipment, laboratory instruments, analyzers, test kits, related supplies, and power generation equipment; and the Engineering segment. The Company generates maximum revenue from the PRC.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.